Quince Therapeutics, Inc.
Quince Therapeutics develops eDSP, which encapsulates desipramine into patient red blood cells using its AIDE drug/device platform for ataxia-telangiectasia.
8-KSep 14Latest SEC filing, period to Sep 8
Sep 14Latest story
Sign in